RecruitingNCT06757257
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
Sponsor
Kissei Pharmaceutical Co., Ltd.
Enrollment
149 participants
Start Date
May 29, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
Eligibility
Inclusion Criteria1
- Patients with chronic idiopathic thrombocytopenic purpura who are treatment with fostamatinib for the first time.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGfostamatinib
oral administration
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06757257